MBX Biosciences seeks up to $482.5 million valuation in US IPO
(Reuters) - MBX Biosciences, which is developing peptide therapies for treating endocrine…
(Reuters) - MBX Biosciences, which is developing peptide therapies for treating endocrine…
(Reuters) - Wall Street's top regulator on Monday gave the nod to new accounting…
By Hannah Lang(Reuters) - Losses from cryptocurrency-related frauds and scams increased…
(Reuters) -Social media platform X was back up on Saturday after it suffered an outage…
(Reuters) - Elon Musk's AI startup xAI has discussed a deal that would give it some…
WASHINGTON (Reuters) - Former U.S. President George W. Bush, a Republican, does not plan…
BEIJING (Reuters) - China is "dissatisfied" with the Dutch goverment's…
(Reuters) - The S&P Dow Jones Indices said on Friday server maker Dell Technologies,…
By Trevor Hunnicutt and Michelle NicholsWASHINGTON (Reuters) - Any Iranian transfer of…
(Reuters) -Apple’s latest iPhone with its A18 chip, which is set to be unveiled at an…
The charting technology is provided by TradingView. Learn how to use theTradingView Stock Screener.
Welcome, Login to your account.
Welcome, Create your new account
A password will be e-mailed to you.